首页> 美国卫生研究院文献>other >Bone regeneration in strong porous bioactive glass (13–93) scaffolds with an oriented microstructure implanted in rat calvarial defects
【2h】

Bone regeneration in strong porous bioactive glass (13–93) scaffolds with an oriented microstructure implanted in rat calvarial defects

机译:强多孔生物活性玻璃(13-93)支架中的骨再生具有植入大鼠颅骨缺陷的定向微观结构的支架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is a need for synthetic bone graft substitutes to repair large bone defects resulting from trauma, malignancy, and congenital diseases. Bioactive glass has attractive properties as a scaffold material but factors that influence its ability to regenerate bone in vivo are not well understood. In the present work, the ability of strong porous scaffolds of 13–93 bioactive glass with an oriented microstructure to regenerate bone was evaluated in vivo using a rat calvarial defect model. Scaffolds with an oriented microstructure of columnar pores (porosity = 50%; pore diameter = 50–150 µm) showed mostly osteoconductive bone regeneration, and new bone formation, normalized to the available pore area (volume) of the scaffolds, increased from 37% at 12 weeks to 55% at 24 weeks. Scaffolds of the same glass with a trabecular microstructure (porosity = 80%; pore width = 100–500 µm), used as the positive control, showed bone regeneration in the pores of 25% and 46% at 12 and 24 weeks, respectively. The brittle mechanical response of the as-fabricated scaffolds changed markedly to an elasto-plastic response in vivo at both implantation times. These results indicate that both groups of 13–93 bioactive glass scaffolds could potentially be used to repair large bone defects, but scaffolds with the oriented microstructure could also be considered for the repair of loaded bone.
机译:需要合成的骨移植物替代物来修复由创伤,恶性肿瘤和先天性疾病引起的大的骨缺损。生物活性玻璃作为支架材料具有吸引人的特性,但是影响其在体内再生骨骼能力的因素尚不十分清楚。在目前的工作中,使用大鼠颅骨缺损模型在体内评估了具有定向微结构的13–93生物活性玻璃的坚固多孔支架再生骨骼的能力。具有柱状孔微结构定向的支架(孔隙度= 50%;孔径= 50–150 µm)显示出大部分具有骨传导性的骨再生,并且根据支架的可用孔面积(体积)归一化,新的骨形成从37%增加在12周时提高到24周时的55%。相同玻璃具有小梁微结构(孔隙度= 80%;孔宽度= 100–500 µm)的支架用作阳性对照,在第12和24周时,其骨再生分别为25%和46%。在两个植入时间,体内制成的支架的脆性机械响应明显改变为体内的弹塑性响应。这些结果表明,两组13-93个生物活性玻璃支架都可以用于修复大的骨缺损,但是具有定向微结构的支架也可以考虑用于修复负载的骨。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号